Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Total Non-Current Liabilities (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $3.0 million as the latest value for Q3 2023.

  • Quarterly Total Non-Current Liabilities rose 60.72% to $3.0 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Sep 2023, up 60.72% year-over-year, with the annual reading at $2.0 million for FY2022, N/A changed from the prior year.
  • Total Non-Current Liabilities hit $3.0 million in Q3 2023 for Bluejay Diagnostics, up from $2.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $1.7 million in Q1 2023.